Nautilus Biotechnology Inc. is a San Carlos, California biotech company building a single-molecule proteomics platform.
Founded in 2016 and based in California, US, Nautilus Biotechnology Inc. develops a single-molecule proteomics platform for analyzing and quantifying the human proteome. The company offers therapeutic development, diagnostics and basic science research, and CEO Sujal Patel leads it. Its Series B round in May 2020 drew investors including Vulcan Capital, Perceptive Advisors, Madrona Venture Group, Defy Ventures, Bolt Ventures, Bezos Expeditions, Andreessen Horowitz and AME Cloud Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in